⌘K
Loading ticker…
Agios Pharmaceuticals, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Agios Pharmaceuticals, Inc. (AGIO) has a 3-month relative strength percentile of 78 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.2%, relative volume 3.49×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 78, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
AGIO is held by 7 ETFs as of Mar 2026. Top owner: XBI at 0.88% weight, $65M notional. Top 3 carry $175M.
Top 7 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| XBIState Street SPDR S&P Biotech ETF | 0.88% | $65M |
| VTIVanguard Total Stock Market ETF | 0.00% | $63M |
| IWMiShares Russell 2000 ETF | 0.06% | $47M |
| VBVanguard Small Cap ETF | 0.03% | $46M |
| VBKVanguard Small-Cap Growth ETF | 0.07% | $26M |
| VXFVanguard Extended Market ETF | 0.03% | $22M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AGIO Jan avg: 3.00% median: 3.11% win: 100% σ: 2.12% n: 4 2022-04-12 → 2026-05-29 | AGIO Feb avg: 10.56% median: 6.76% win: 75% σ: 23.86% n: 4 2022-04-12 → 2026-05-29 | AGIO Mar avg: -6.11% median: -9.39% win: 25% σ: 12.61% n: 4 2022-04-12 → 2026-05-29 | AGIO Apr avg: -5.76% median: -0.43% win: 40% σ: 14.27% n: 5 2022-04-12 → 2026-05-29 | AGIO May avg: 4.81% median: 8.08% win: 80% σ: 9.42% n: 5 2022-04-12 → 2026-05-29 | AGIO Jun avg: 12.05% median: 12.95% win: 100% σ: 6.26% n: 4 2022-04-12 → 2026-05-29 (current) | AGIO Jul avg: 2.61% median: 2.45% win: 50% σ: 8.56% n: 4 2022-04-12 → 2026-05-29 | AGIO Aug avg: 5.48% median: 2.37% win: 75% σ: 8.69% n: 4 2022-04-12 → 2026-05-29 | AGIO Sep avg: 1.09% median: 1.61% win: 50% σ: 9.34% n: 4 2022-04-12 → 2026-05-29 | AGIO Oct avg: -2.50% median: -1.31% win: 25% σ: 9.48% n: 4 2022-04-12 → 2026-05-29 | AGIO Nov avg: 4.11% median: 7.62% win: 75% σ: 27.35% n: 4 2022-04-12 → 2026-05-29 | AGIO Dec avg: -14.53% median: -6.81% win: 25% σ: 20.36% n: 4 2022-04-12 → 2026-05-29 |